High early peak creatine kinase after thrombolysis in patients with acute anterior infarction predicts poor left

D Freimark1, S Matetzky, H Hod

  • 1Heart Institute, Sheba Medical Center, Tel-Hashomer, Tel-Aviv University, Israel.

Cardiology
|January 1, 1995
PubMed

Insights

Following thrombolysis for acute myocardial infarction (AMI), peak creatine kinase (CK) levels still indicate heart damage. Higher peak CK values correlate with reduced left ventricular ejection fraction (LVEF), showing impaired heart function.

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • Successful thrombolysis in acute myocardial infarction (AMI) modifies creatine kinase (CK) release patterns.
  • Key alterations include an earlier CK peak and higher peak values relative to infarct size.

Purpose of the Study:

  • To investigate if peak CK magnitude post-thrombolysis accurately reflects myocardial damage extent.
  • To correlate peak CK levels with left ventricular ejection fraction (LVEF) in patients with anterior AMI.

Main Methods:

  • Analysis of 114 patients with first anterior AMI treated with thrombolysis.
  • Correlation of peak CK values with LVEF at admission and 2 months post-treatment.
  • Categorization of patients based on early peak CK (< or = 12 hours).

Main Results:

  • A significant linear relationship (p < 0.001) was found between peak CK and LVEF at both time points.
  • High peak CK (>= 1,500 IU/l) was significantly associated with lower LVEF (p < 0.001).
  • Patients with high early peak CK showed a higher incidence of poor LVEF (p < 0.05).

Conclusions:

  • Peak CK magnitude remains a valuable indicator of myocardial damage extent after successful thrombolysis for AMI.
  • Elevated peak CK levels post-thrombolysis predict worse left ventricular function.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...